GoodRx Holdings (GDRX) Short term Debt (2019 - 2026)

GoodRx Holdings has disclosed Short term Debt across 8 years of filings, most recently posting $5.0 million for Q2 2026.

• In Q2 2026, Short term Debt changed 0.0% year-over-year to $5.0 million; the TTM figure through Jun 2026 stood at $5.0 million (changed 0.0% YoY), while the FY2025 annual figure was $5.0 million, changed 0.0% from the prior year.
• Short term Debt came in at $5.0 million for Q2 2026 at GoodRx Holdings, roughly flat from $5.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $8.8 million in Q4 2023 to a low of $3.8 million in Q3 2024.
• Average Short term Debt over 5 years is $6.2 million, with a median of $7.0 million recorded in 2022.
• Year-over-year, Short term Debt plunged 46.65% in 2024 and surged 33.33% in 2025.
• Over 5 years, Short term Debt stood at $7.0 million in 2022, then grew by 25.01% to $8.8 million in 2023, then slumped by 43.1% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025, then changed by 0.0% to $5.0 million in 2026.
• Per Business Quant data, the three most recent Short term Debt figures were $5.0 million in Q2 2026, $5.0 million in Q1 2026, and $5.0 million in Q4 2025.